As one of 24 PIs in Norway (all disciplines included), Tor Erik Rusten, who is group leader at Institute for Cancer Research and PI in Centre for Cancer Cell Reprogramming (CanCell), has been awarded a prestigious “Toppforsk” grant from the Research Council for the project “Tumor-Host Biology”.
Each of the 24 projects receive between 15 and 25 mill NOK. The grants are aimed at research communities that have the potential to become international leaders within their fields.
Two of the 24 selected projects are led by group leaders at the Institute for Cancer Research. The other is Karl-Erik Malmberg from the Department of Cancer Immunology.
Nominating outstanding scientists, closing date March 1st:Excellent Researcher Award and Early Career Award 2018
Oslo University Hospital announce research awards in the following categories for 2018:
- Excellent Researcher Award (300.000 NOK)
- Early Career Award (two prizes of 150.000 NOK)
The candidates must be employed by Oslo University Hospital or University of Oslo, and member of a research group at one of these institutions.
The Norwegian government is aiming for long-term efforts to build research communities on the highest level. In total 24 Norwegian projects, all disciplines included, receive between 15 and 25 mill NOK. The grants are aimed at research communities that have the potential to become international leaders within their fields.
Two of the 24 selected projects are led by group leaders at the Institute for Cancer Research. The other is Tor Erik Rusten from the Department of Molecular Cell Biology.
Professor Karl-Johan Malmberg, head of the c at the Department of Cancer Immunology at the Institute for Cancer research, was recently interviewed on radio by the Norwegian Broadcasting Corporation (NRK) in connection with a news item on NRK radio and on their home page about recent research progress on the subject "how killer cells may overcome cancer" (entitled "Drepeceller kan ta knekken på kreft").
The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) aims to profile ongoing excellent research in the region by calling special attention to a "Scientist of the Month".
This honour recently went to Therese Sørlie, department head at Department of Cancer Genetics at the Institute for Cancer Research and leader of the "Breast tumor initiation and progression" group. She is presented in a feature article (in Norwegian) entitled "Why does cancer become cancer?".
Rusten group research project on cell organisation and tumor growth highlighted by the Norwegian Cancer Society
The Norwegian Cancer Society awarded NOK 173.8 millions NOK to cancer research through the annual open announcement in 2017. They publish popular science articles about research projects supported by them regularly.
The research of Tor Erik Rusten and his coworkers in from the Tumor-Host Biology research group at the Department of Molecular Cell Biology at the Institute for Cancer Research has recently been presented in an article (in Norwegian) entitled "Double agent in the body's cells makes tumors grow". Here it is explained how tumor cells lose orientation and grow uncontrollably when the "double agent" protein LKB1 leads the cells in the wrong direction under certain conditions.